fda bpc-157 unapproved drug warning letter Bpc 157 peptide 10mg 5-Amino-1MQ — 50mg | Capsules:30

fda bpc-157 unapproved drug warning letter Bpc 157 peptide 10mg 5-Amino-1MQ — 50mg | Capsules:30

5-Amino-1MQ — 50mg | NNMT Inhibitor (NAD+ Axis) - VPeptide 5-Amino-1MQ Canada (50 mg): Ultra-Pure Metabolic Research Compound

The current BPC-157 page lists lot 031826213049, and the linked 5mg COA carries the same lot

peptide 10mg

Capsules:30

Decreased D1 expression in the anterior cingulate cortex of ADHD individuals was associated with severe hyperactivity, activated microglia in the dorsolateral prefrontal and the orbitofrontal cortices, and deficits in attentional ability and processing speed (Yokokura et al., 2021)